{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:24:16Z","timestamp":1792610656681,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009133","name":"Karlsruhe Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022230","name":"Princess Nourah bint Abdulrahman University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["PNURSP2025R3"],"award-info":[{"award-number":["PNURSP2025R3"]}],"id":[{"id":"10.13039\/501100022230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109329","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:08:05Z","timestamp":1764868085000},"page":"109329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole\/3-cyanopyridin-2-one hybrids as dual EGFR\/BRAFV600E inhibitors"],"prefix":"10.1016","volume":"168","author":[{"given":"Lamya H.","family":"Al-Wahaibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham A.","family":"Abou-Zied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa G.M.","family":"Youssif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Br\u00e4se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109329_bb0005","doi-asserted-by":"crossref","first-page":"1447618","DOI":"10.3389\/fchem.2024.1447618","article-title":"Design and synthesis of new 1, 2, 4-oxadiazole\/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors","volume":"12","author":"Mohamed","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.109329_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136953","article-title":"Design and synthesis of new quinoline-ester\/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases","volume":"1297","author":"Mohassab","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109329_bb0015","series-title":"Improving Screening for Colorectal Cancer in Young Adults","author":"Palmer","year":"2024"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109329_bb0020","first-page":"1932","article-title":"Design, synthesis, and antiproliferative activity of quinazolin-4-one\/chalcone hybrids via the egfr inhibition pathway","volume":"23","author":"Hisham","year":"2023","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem.-Anti-Cancer Agents)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/biomedicines12010183","article-title":"Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review","volume":"12","author":"Eslami","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109329_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/cancers15030654","article-title":"Immunotherapy and the combination with targeted therapies for advanced hepatocellular carcinoma","volume":"15","author":"Laface","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70470","article-title":"Molecular mechanisms, endurance athlete, and synergistic therapeutic effects of marine-derived antioxidant astaxanthin supplementation and exercise in cancer, metabolic diseases, and healthy individuals","volume":"13","author":"Nie","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.bioorg.2025.109329_bb0040","first-page":"1","article-title":"Chemoimmunotherapy synergism: mechanisms and clinical applications","author":"Shaik","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109329_bb0045","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.3390\/ijms24109104","article-title":"Design, synthesis, antiproliferative actions, and dft studies of new bis\u2013pyrazoline derivatives as dual egfr\/brafv600e inhibitors","volume":"24","author":"Al-Wahaibi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0050","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/14756366.2022.2151593","article-title":"Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway","volume":"38","author":"Al-Wahaibi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109329_bb0055","first-page":"1","article-title":"The use of different types of networks, alone and in combination, for drug target identification","author":"Parini","year":"2025","journal-title":"Br. J. Pharmacol. May"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109329_bb0060","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2174\/1381612822666160224142812","article-title":"Polypharmacology in drug discovery: a review from systems pharmacology perspective","volume":"22","author":"Zhang","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109329_bb0065","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/ph16111522","article-title":"Quinazolin-4-one\/3-cyanopyridin-2-one hybrids as dual inhibitors of EGFR and BRAFV600E: design, synthesis, and antiproliferative activity","volume":"16","author":"Al-Wahaibi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/ph16071039","article-title":"Design, synthesis, and biological evaluation of indole-2-carboxamides as potential multi-target antiproliferative agents","volume":"16","author":"Al-Wahaibi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109329_bb0075","first-page":"S13","article-title":"An open-label, multi-center phase 2 study of the BRAF inhibitor vemurafenib in patients with metastatic or unresectable papillary thyroid cancer (PTC) positive for the BRAF V600 mutation and resistant to radioactive iodine (NCT01286753, No25530)","author":"Brose","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0080","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1210\/jc.2014-2246","article-title":"Efficacy and tolerability of vemurafenib in patients with BRAFV600E-positive papillary thyroid cancer: MD Anderson Cancer Center off label experience","volume":"100","author":"Dadu","year":"2015","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1764","article-title":"A comprehensive overview of the molecular features and therapeutic targets in BRAFV600E-mutant colorectal cancer","volume":"14","author":"Gu","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109329_bb0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)","volume":"169","author":"Murphy","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109329_bb0095","first-page":"20","article-title":"Efficacy of sorafenib-based therapies for non-small cell lung cancer","volume":"12","author":"Hendrixson","year":"2024","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0100","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s10143-024-02664-x","article-title":"The effects of dabrafenib and\/or trametinib treatment in Braf V600-mutant glioma: a systematic review and meta-analysis","volume":"47","author":"Lei","year":"2024","journal-title":"Neurosurg. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109329_bb0105","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.21037\/tlcr-24-358","article-title":"Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients","volume":"13","author":"Weng","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109329_bb0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations","volume":"373","author":"Hyman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109329_bb0115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/2159-8290.CD-12-0531","article-title":"Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas","volume":"3","author":"Montero-Conde","year":"2013","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17425247.2021.1825377","article-title":"Targeted drug therapy in non-small cell lung cancer: clinical significance and possible solutions-part I","volume":"18","author":"Upadhya","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7387","key":"10.1016\/j.bioorg.2025.109329_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","author":"Prahallad","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109329_bb0130","doi-asserted-by":"crossref","DOI":"10.53388\/2025825002","article-title":"Abnormal activation of the Ras\/MAPK signaling pathway in oncogenesis and progression","volume":"8","author":"Xu","year":"2025","journal-title":"Cancer Adv."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/receptors3010005","article-title":"Role and function of receptor tyrosine kinases in BRAF mutant cancers","volume":"3","author":"Biersack","year":"2024","journal-title":"Receptors"},{"key":"10.1016\/j.bioorg.2025.109329_bb0140","doi-asserted-by":"crossref","first-page":"1541846","DOI":"10.3389\/fchem.2024.1541846","article-title":"Design, synthesis, and apoptotic antiproliferative action of new benzimidazole\/1, 2, 3-triazole hybrids as EGFR inhibitors","volume":"12","author":"Ahmed","year":"2025","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109329_bb0145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/molecules29020446","article-title":"Benzimidazole-based derivatives as apoptotic antiproliferative agents: design, synthesis, docking, and mechanistic studies","volume":"29","author":"Youssif","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109329_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2022.11.006","article-title":"Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1\/BRCA1 pathway","volume":"168","author":"Yanaihara","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109329_bb0155","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/cbdd.13974","article-title":"Insights into the structure and drug design of benzimidazole derivatives targeting the epidermal growth factor receptor (EGFR)","volume":"100","author":"Abdullah","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109329_bb0160","article-title":"Advances in synthesis, medicinal properties and biomedical applications of pyridine derivatives: a comprehensive review","volume":"12","author":"Sahu","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0165","doi-asserted-by":"crossref","first-page":"2300067","DOI":"10.1002\/ardp.202300067","article-title":"A review: biological activities of novel cyanopyridine derivatives","volume":"356","author":"Wu","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109329_bb0170","article-title":"Novel 2-alkoxy-3-cyanopyridine derivatives as cholinesterase inhibitors: synthesis, biological evaluation, and in silico investigations","volume":"23","author":"Kadi","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2174\/1570179417666200628020602","article-title":"Synthesis of new cyanopyridine scaffolds and their biological activities","volume":"17","author":"Alhakamy","year":"2020","journal-title":"Curr. Org. Synth."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109329_bb0180","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.3390\/molecules28186586","article-title":"Design, synthesis, and biological evaluation of novel 3-cyanopyridone\/pyrazoline hybrids as potential apoptotic antiproliferative agents targeting EGFR\/BRAFV600E inhibitory pathways","volume":"28","author":"Al-Wahaibi","year":"2023","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0185","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/molecules27072259","article-title":"FDA-approved small molecule compounds as drugs for solid cancers from early 2011 to the end of 2021","volume":"27","author":"Sochacka-\u0106wik\u0142a","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109329_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200464","article-title":"Discovery of new cyanopyridine\/chalcone hybrids as dual inhibitors of EGFR\/BRAFV600E with promising antiproliferative properties","volume":"356","author":"Abou-Zied","year":"2023","journal-title":"Arch. Pharm."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0195","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/ptr.8215","article-title":"The interplay of exercise and polyphenols in cancer treatment: a focus on oxidative stress and antioxidant mechanisms","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109329_bb0200","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/antiox9111156","article-title":"Redox potential of antioxidants in cancer progression and prevention","volume":"9","author":"George","year":"2020","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109329_bb0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/antiox14091121","article-title":"Oxidative stress and antioxidants in glioblastoma: mechanisms of action, therapeutic effects and future directions","volume":"14","author":"Nowacka","year":"2025","journal-title":"Antioxidants"},{"issue":"22","key":"10.1016\/j.bioorg.2025.109329_bb0210","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.3390\/ijms252212387","article-title":"Oxidative stress and cancer therapy: controlling cancer cells using reactive oxygen species","volume":"25","author":"Ju","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109329_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918755391","article-title":"Reactive oxygen species: a key constituent in cancer survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark. Insights"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2015.07.008","article-title":"Reactive oxygen species in redox cancer therapy","volume":"367","author":"Tong","year":"2015","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109329_bb0225","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2967\/jnumed.120.256974","article-title":"Latest advances in imaging oxidative stress in cancer","volume":"62","author":"Greenwood","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109329_bb0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bcp.2015.07.017","article-title":"Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy","volume":"98","author":"Le\u00f3n-Gonz\u00e1lez","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109329_bb0235","doi-asserted-by":"crossref","first-page":"1076383","DOI":"10.3389\/fchem.2022.1076383","article-title":"Design and synthesis of new thiazolidinone\/uracil derivatives as antiproliferative agents targeting EGFR and\/or BRAFV600E","volume":"10","author":"Alshammari","year":"2022","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109329_bb0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/ph16030467","article-title":"One-pot synthesis of 1-Thia-4-azaspiro [4.4\/5] alkan-3-ones via Schiff base: design, synthesis, and apoptotic antiproliferative properties of dual EGFR\/BRAFV600E inhibitors","volume":"16","author":"Al-Wahaibi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0245","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/ph16071014","article-title":"Synthesis and structure determination of substituted thiazole derivatives as EGFR\/BRAFV600E dual inhibitors endowed with antiproliferative activity","volume":"16","author":"Al-Wahaibi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109329_bb0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcice.2007.01.003","article-title":"Synthesis of 2-mercaptobenzimidazole from the reaction of o-phenylene diamine and carbon disulfide in the presence of potassium hydroxide","volume":"38","author":"Wang","year":"2007","journal-title":"J. Chin. Inst. Chem. Eng."},{"key":"10.1016\/j.bioorg.2025.109329_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.05.015","article-title":"Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents","volume":"176","author":"Hisham","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109329_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111522","article-title":"Quinazolin-4-one\/3-cyanopyridin-2-one hybrids as dual inhibitors of EGFR and BRAF(V600E): design, synthesis, and antiproliferative activity","volume":"16","author":"Al-Wahaibi","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"24","key":"10.1016\/j.bioorg.2025.109329_bb0265","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.3390\/molecules27248765","article-title":"Design, synthesis and biological evaluation of syn and anti-like double warhead quinolinones bearing dihydroxy naphthalene moiety as epidermal growth factor receptor inhibitors with potential apoptotic antiproliferative action","volume":"27","author":"El-Sheref","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109329_bb0270","first-page":"697","article-title":"Design, synthesis and antiproliferative evaluation of novel 1, 2, 4-triazole\/schiff base hybrids with EGFR and B-RAF inhibitory activities","volume":"19","author":"El-Sherief","year":"2019","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem.-Anti-Cancer Agents)"},{"key":"10.1016\/j.bioorg.2025.109329_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.05.040","article-title":"5-Chlorobenzofuran-2-carboxamides: from allosteric CB1 modulators to potential apoptotic antitumor agents","volume":"177","author":"Youssif","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109329_bb0280","doi-asserted-by":"crossref","first-page":"1432920","DOI":"10.3389\/fchem.2024.1432920","article-title":"Design and synthesis new indole-based aromatase\/iNOS inhibitors with apoptotic antiproliferative activity","volume":"12","author":"Al-Wahaibi","year":"2024","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/antiox14010104","article-title":"Role of oxidative stress in the occurrence, development, and treatment of breast cancer","volume":"14","author":"Dong","year":"2025","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109329_bb0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/cells14070511","article-title":"Oxidative stress and redox imbalance: common mechanisms in cancer stem cells and neurodegenerative diseases","volume":"14","author":"Selvaraj","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109329_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3329\/dujps.v24i1.82414","article-title":"Synthesis and assessment of antiproliferative, antioxidant, and in silico features of (E)-3-(4-nitrophenyl)-1-phenyl-prop-2-en-1-one and its two pyrazole derivatives","volume":"24","author":"Haque","year":"2025","journal-title":"Dhaka Univ. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109329_bb0300","first-page":"1","article-title":"Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches","author":"Nossier","year":"2025","journal-title":"Mol. Divers."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109329_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/cssc.202402383","article-title":"Guidelines for evaluating the antioxidant activity of lignin via the 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay","volume":"18","author":"Diment","year":"2025","journal-title":"ChemSusChem"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109329_bb0310","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0010(20000901)80:11<1686::AID-JSFA694>3.0.CO;2-Y","article-title":"Evaluation of free radical scavenging of dietary carotenoids by the stable radical 2, 2-diphenyl-1-picrylhydrazyl","volume":"80","author":"Jim\u00e9nez-Escrig","year":"2000","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.bioorg.2025.109329_bb0315","series-title":"Review on Discovery Studio: An Important Tool for Molecular Docking","author":"Pawar","year":"2021"},{"key":"10.1016\/j.bioorg.2025.109329_bb0320","series-title":"Molecular Docking studies on the Anti-fungal Activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA Discovery Studio Visualizer 21.1.0.0","author":"Sharma","year":"2021"},{"issue":"48","key":"10.1016\/j.bioorg.2025.109329_bb0325","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7315","key":"10.1016\/j.bioorg.2025.109329_bb0330","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109329_bb0335","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1021\/acsomega.4c08562","article-title":"Uncovering the binding mechanism of mutated omicron variants via computational strategies","volume":"10","author":"Haider","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109329_bb0340","series-title":"A Simple Overview for Proteins Molecular Dynamics Simulations Using GROMACS","first-page":"355","author":"Baba","year":"2024"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109329_bb0345","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1007\/s00044-012-0369-3","article-title":"Antibacterial and antifungal screening of newly synthesized benzimidazole-clubbed chalcone derivatives","volume":"22","author":"Parikh","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109329_bb0350","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0960-894X(02)00346-3","article-title":"Synthesis and antiparasitic activity of 1H-benzimidazole derivatives","volume":"12","author":"Valdez","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:46:51Z","timestamp":1767692811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":70,"alternative-id":["S004520682501209X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109329","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole\/3-cyanopyridin-2-one hybrids as dual EGFR\/BRAFV600E inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109329"}}